Allogene Therapeutics stock price
알로진 테라퓨틱스NASDAQ:ALLO · Nasdaq · Healthcare$1.50-2.60%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Allogene Therapeutics last closed at $1.50 (-2.60%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -3.0×. Its overall grade ranks 232 of 739 stocks in Healthcare.
About this company
Allogene Therapeutics last closed at $1.50 (-2.60%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 232/739
Valuation grade B-
Related stocks
- AbbVieCustomer
CAR-T 등 세포치료제 협업·라이선스 파트너로 연관
- PfizerCompetitor
혈액암·면역질환 등에서 세포치료/면역항암 경쟁
- Bristol Myers SquibbCompetitor
CAR-T 상용화 강자로 Allogene의 세포치료 경쟁사
About Allogene Therapeutics
- What technical signals does Allogene Therapeutics (ALLO) have?
- Allogene Therapeutics current technical signals: no active technical signal.
- Is Allogene Therapeutics a cup-and-handle pattern?
- No. Allogene Therapeutics has no valid Cup signal right now.
- What published figures are available for Allogene Therapeutics?
- Market cap: $337.09M. Trailing 12 months PER: -3.0×. Latest quarter PBR: 1.13×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Allogene Therapeutics, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy